×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Ra Pharmaceuticals, Inc.. (RARX) NASDAQ

$48 - (-)

Market Cap: $2.26B

As of 04/01/20 12:00 AM EDT. Market closed.

(RARX)

Ra Pharmaceuticals, Inc.. (RARX)
NASDAQ

$48
- (-)

Market Cap: $2.26B

As of 04/01/20 12:00 AM EDT. Market closed.

Add to Portfolio

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, ... read more

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Douglas A. Treco
Full Time Employees
89
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.98M
URL
Address
87 CambridgePark Drive, MA, Cambridge, 02140.
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Douglas A. Treco
Full Time Employees
89
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.98M
Address
87 CambridgePark Drive, MA, Cambridge, 02140.
PRICE CHART FOR RA PHARMACEUTICALS, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$48
Days Range
- - -
52 week range
$19.64 - $48.02
Volume
0
Avg. Volume (30 days)
1,446,350
Market Cap
$2.26B
Dividend Yield
-
P/E
-
Shares Outstanding
47,143,000
Open
-
Previous Close
$48
Days Range
- - -
52 week range
$19.64 - $48.02
Volume
0
Avg. Volume (30 days)
1,446,350
Market Cap
$2.26B
Dividend Yield
-
P/E
-
Shares Outstanding
47,143,000
FINANCIAL STATEMENTS FOR RA PHARMACEUTICALS, INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR RA PHARMACEUTICALS, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Treco Douglas APresident and CEOApr 02, 2020 Option Exercise$48.00234,70711,265,9360Apr 03, 2020, 09:02 AM
Lubner David CharlesExecutive VP and CFOApr 02, 2020 Option Exercise$48.0015,622749,8560Apr 03, 2020, 09:02 AM
Ricardo AlonsoSee RemarksApr 02, 2020 Option Exercise$48.002,973142,7040Apr 03, 2020, 09:02 AM
Read SimonChief Scientific OfficerApr 02, 2020 Option Exercise$48.0012,595604,5600Apr 03, 2020, 09:02 AM
Farzaneh-Far RaminChief Medical OfficerApr 02, 2020 Option Exercise$48.0014,492695,6160Apr 03, 2020, 09:01 AM
King John CChief Commercial OfficerApr 02, 2020 Option Exercise$48.0010,823519,5040Apr 03, 2020, 09:01 AM
Shah Rajeev M.DirectorApr 02, 2020 Option Exercise$48.004,858,260233,196,4800Apr 03, 2020, 09:00 AM
RA CAPITAL MANAGEMENT, L.P.DirectorApr 02, 2020 Option Exercise$48.004,858,260233,196,4800Apr 03, 2020, 12:00 AM
Ricardo AlonsoSee RemarksMar 17, 2020 Sale$44.252,288101,2440Mar 18, 2020, 06:00 PM
Farzaneh-Far RaminChief Medical OfficerMar 16, 2020 Option Exercise$5.6010,59559,33217,727Mar 18, 2020, 06:00 PM
Farzaneh-Far RaminChief Medical OfficerMar 16, 2020 Sale$45.1610,595478,5217,132Mar 18, 2020, 06:00 PM
Farzaneh-Far RaminChief Medical OfficerFeb 18, 2020 Option Exercise$5.6010,59559,33217,727Feb 20, 2020, 06:52 PM
Farzaneh-Far RaminChief Medical OfficerFeb 18, 2020 Sale$46.6110,595493,8507,132Feb 20, 2020, 06:52 PM
Ricardo AlonsoSee RemarksJan 17, 2020 Sale$47.022,285107,4412,288Jan 21, 2020, 06:32 PM
Farzaneh-Far RaminChief Medical OfficerJan 15, 2020 Option Exercise$5.6010,59559,33217,727Jan 16, 2020, 06:01 PM
Farzaneh-Far RaminChief Medical OfficerJan 15, 2020 Sale$46.9510,595497,4417,132Jan 16, 2020, 06:01 PM
Ricardo AlonsoSee RemarksDec 17, 2019 Sale$47.082,285107,5684,573Dec 18, 2019, 06:01 PM
Read SimonChief Scientific OfficerDec 17, 2019 Option Exercise$2.8710,00028,70016,234Dec 18, 2019, 06:01 PM
Read SimonChief Scientific OfficerDec 17, 2019 Sale$47.0810,000470,8216,234Dec 18, 2019, 06:01 PM
Farzaneh-Far RaminChief Medical OfficerDec 16, 2019 Option Exercise$5.6010,59559,33217,727Dec 18, 2019, 06:00 PM
Farzaneh-Far RaminChief Medical OfficerDec 16, 2019 Sale$47.2310,595500,3517,132Dec 18, 2019, 06:00 PM
Farzaneh-Far RaminChief Medical OfficerNov 15, 2019 Option Exercise$5.6010,59559,33217,727Nov 18, 2019, 05:08 PM
Farzaneh-Far RaminChief Medical OfficerNov 15, 2019 Sale$46.6610,595494,3197,132Nov 18, 2019, 05:08 PM
Read SimonChief Scientific OfficerNov 14, 2019 Option Exercise$2.8710,00028,70016,234Nov 18, 2019, 05:07 PM
Read SimonChief Scientific OfficerNov 14, 2019 Sale$46.6810,000466,8086,234Nov 18, 2019, 05:07 PM
Ricardo AlonsoSee RemarksOct 17, 2019 Sale$46.702,285106,7106,858Oct 17, 2019, 08:11 PM
Read SimonChief Scientific OfficerOct 16, 2019 Option Exercise$2.8710,00028,70016,234Oct 17, 2019, 07:00 PM
Read SimonChief Scientific OfficerOct 16, 2019 Sale$46.8710,000468,7266,234Oct 17, 2019, 07:00 PM
Farzaneh-Far RaminChief Medical OfficerOct 15, 2019 Option Exercise$5.6010,59559,33217,727Oct 17, 2019, 07:00 PM
Farzaneh-Far RaminChief Medical OfficerOct 15, 2019 Sale$46.8910,595496,7697,132Oct 17, 2019, 07:00 PM
Farzaneh-Far RaminChief Medical OfficerSep 16, 2019 Option Exercise$5.6010,59559,33217,727Sep 16, 2019, 06:44 PM
Farzaneh-Far RaminChief Medical OfficerSep 16, 2019 Sale$25.2610,595267,6757,132Sep 16, 2019, 06:44 PM
Read SimonChief Scientific OfficerSep 12, 2019 Option Exercise$2.8710,00028,70016,234Sep 16, 2019, 06:43 PM
Read SimonChief Scientific OfficerSep 12, 2019 Sale$25.4110,000254,0506,234Sep 16, 2019, 06:43 PM
Read SimonChief Scientific OfficerAug 23, 2019 Option Exercise$2.8710,00028,70016,234Aug 27, 2019, 06:01 PM
Read SimonChief Scientific OfficerAug 23, 2019 Sale$27.7710,000277,7036,234Aug 27, 2019, 06:01 PM
Farzaneh-Far RaminChief Medical OfficerAug 23, 2019 Option Exercise$5.6010,59559,33217,727Aug 27, 2019, 06:01 PM
Farzaneh-Far RaminChief Medical OfficerAug 23, 2019 Sale$27.7710,595294,2267,132Aug 27, 2019, 06:01 PM
Ricardo AlonsoSee RemarksAug 23, 2019 Sale$27.892,28563,7409,143Aug 27, 2019, 06:00 PM
Read SimonChief Scientific OfficerJul 17, 2019 Option Exercise$2.8710,00028,70016,234Jul 18, 2019, 07:04 PM
Read SimonChief Scientific OfficerJul 17, 2019 Sale$32.9510,000329,4796,234Jul 18, 2019, 07:04 PM
Farzaneh-Far RaminChief Medical OfficerJul 15, 2019 Option Exercise$5.6010,59559,33217,727Jul 16, 2019, 07:15 PM
Farzaneh-Far RaminChief Medical OfficerJul 15, 2019 Sale$33.1010,595350,64711,348Jul 16, 2019, 07:15 PM
Ricardo AlonsoSee RemarksJun 21, 2019 Sale$23.722,85767,78211,428Jun 25, 2019, 04:16 PM
Read SimonChief Scientific OfficerJun 18, 2019 Option Exercise$2.8710,00028,70016,234Jun 19, 2019, 09:03 PM
Read SimonChief Scientific OfficerJun 18, 2019 Sale$22.2510,000222,4676,648Jun 19, 2019, 09:03 PM
Farzaneh-Far RaminChief Medical OfficerJun 17, 2019 Option Exercise$5.6010,59559,33217,727Jun 19, 2019, 09:03 PM
Farzaneh-Far RaminChief Medical OfficerJun 17, 2019 Sale$21.8410,595231,38414,316Jun 19, 2019, 09:03 PM
King John CChief Commercial OfficerApr 16, 2019 Option Exercise$21.934,50698,81710,823Apr 18, 2019, 05:55 PM
Lubner David CharlesExecutive V.P. & CFOFeb 01, 2019 Option Exercise$21.003,29169,1117,126Feb 05, 2019, 07:39 PM
Read SimonChief Scientific OfficerFeb 01, 2019 Option Exercise$21.002,93361,5936,234Feb 05, 2019, 07:39 PM
Farzaneh-Far RaminChief Medical OfficerFeb 01, 2019 Option Exercise$21.003,28568,9857,132Feb 05, 2019, 07:38 PM
Treco Douglas APresident and CEOFeb 01, 2019 Option Exercise$21.006,327132,867218,799Feb 05, 2019, 07:38 PM
NEW ENTERPRISE ASSOCIATES 13 LP10% OwnerDec 14, 2018 Buy$15.50645,1619,999,9966,135,234Dec 14, 2018, 06:22 PM
RA CAPITAL MANAGEMENT, LLCDirectorDec 12, 2018 Buy$15.501,006,45215,600,0064,858,260Dec 14, 2018, 06:17 PM
Shah Rajeev M.DirectorDec 14, 2018 Buy$15.501,006,45215,600,0064,858,260Dec 14, 2018, 06:14 PM
NEW ENTERPRISE ASSOCIATES 13 LP10% OwnerFeb 16, 2018 Buy$6.002,000,00012,000,0005,490,073Feb 21, 2018, 04:19 PM
Shah Rajeev M.DirectorFeb 14, 2018 Buy$6.002,500,00015,000,0003,851,808Feb 16, 2018, 04:42 PM
RA CAPITAL MANAGEMENT, LLCDirectorFeb 14, 2018 Buy$6.002,500,00015,000,0003,851,808Feb 16, 2018, 04:42 PM
Novartis Bioventures Ltd10% OwnerJun 19, 2017 Sale$22.023,22070,8992,251,457Jun 20, 2017, 04:41 PM
Novartis Bioventures Ltd10% OwnerJun 16, 2017 Sale$21.2453,2001,130,2072,254,677Jun 20, 2017, 04:41 PM
Novartis Bioventures Ltd10% OwnerJun 08, 2017 Sale$22.0070015,4002,307,877Jun 12, 2017, 04:12 PM
Novartis Bioventures Ltd10% OwnerJun 07, 2017 Sale$22.114,840106,9992,308,577Jun 08, 2017, 04:33 PM
Novartis Bioventures Ltd10% OwnerJun 06, 2017 Sale$22.987,274167,1612,313,417Jun 08, 2017, 04:33 PM
Novartis Bioventures Ltd10% OwnerJun 02, 2017 Sale$23.4714,867348,9492,325,471Jun 06, 2017, 04:27 PM
Novartis Bioventures Ltd10% OwnerJun 05, 2017 Sale$23.114,780110,4882,320,691Jun 06, 2017, 04:27 PM
Novartis Bioventures Ltd10% OwnerJun 01, 2017 Sale$23.8910,722256,1762,340,338Jun 02, 2017, 04:25 PM
Novartis Bioventures Ltd10% OwnerMay 31, 2017 Sale$23.9435,539850,8962,351,060Jun 02, 2017, 04:25 PM
Novartis Bioventures Ltd10% OwnerMay 26, 2017 Sale$25.145,300133,2672,386,599May 30, 2017, 04:29 PM
Novartis Bioventures Ltd10% OwnerMay 25, 2017 Sale$25.00531,3252,391,899May 30, 2017, 04:29 PM
Novartis Bioventures Ltd10% OwnerMay 24, 2017 Sale$25.0117,451436,3642,391,952May 25, 2017, 04:57 PM
Novartis Bioventures Ltd10% OwnerMay 18, 2017 Sale$25.509,019229,9642,409,403May 22, 2017, 06:50 PM
Novartis Bioventures Ltd10% OwnerMay 17, 2017 Sale$25.5122,534574,9012,418,422May 18, 2017, 04:36 PM
Novartis Bioventures Ltd10% OwnerMay 16, 2017 Sale$26.3320,081528,7252,440,956May 18, 2017, 04:36 PM
Novartis Bioventures Ltd10% OwnerFeb 23, 2017 Sale$21.044,999105,1602,539,904May 02, 2017, 05:22 PM
Novartis Bioventures Ltd10% OwnerFeb 22, 2017 Sale$21.8674916,3702,544,903May 02, 2017, 05:22 PM
Novartis Bioventures Ltd10% OwnerMar 01, 2017 Sale$20.917,778162,6582,461,037May 02, 2017, 05:22 PM
Novartis Bioventures Ltd10% OwnerFeb 28, 2017 Sale$20.867,847163,6702,468,815May 02, 2017, 05:22 PM
Novartis Bioventures Ltd10% OwnerFeb 27, 2017 Sale$20.9657,8441,212,3062,476,662May 02, 2017, 05:22 PM
Novartis Bioventures Ltd10% OwnerFeb 24, 2017 Sale$20.935,398113,0002,534,506May 02, 2017, 05:22 PM
Novo A/S10% OwnerOct 31, 2016 Buy$13.00246,1543,200,0022,031,562Nov 02, 2016, 04:54 PM
Shah Rajeev M.DirectorOct 31, 2016 Buy$13.00161,5382,099,9941,351,808Oct 31, 2016, 08:46 PM
RA CAPITAL MANAGEMENT, LLCDirectorOct 31, 2016 Buy$13.00161,5382,099,9941,351,808Oct 31, 2016, 07:41 PM
Weller Harry R10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:52 PM
Weller Harry R10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:52 PM
Weller Harry R10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:52 PM
MORGENTHALER VENTURE PARTNERS IX LP10% OwnerOct 31, 2016 Buy$13.00263,5383,425,9942,745,846Oct 31, 2016, 04:51 PM
MORGENTHALER VENTURE PARTNERS IX LP10% OwnerOct 31, 2016 Sale$13.003404,42079,821Oct 31, 2016, 04:51 PM
MORGENTHALER VENTURE PARTNERS IX LP10% OwnerOct 31, 2016 Option Exercise$0.0763,0194,41180,161Oct 31, 2016, 04:51 PM
Viswanathan Ravi10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:51 PM
Viswanathan Ravi10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:51 PM
Viswanathan Ravi10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:51 PM
SANDELL SCOTT D10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:51 PM
SANDELL SCOTT D10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:51 PM
SANDELL SCOTT D10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:51 PM
Lettmann JasonDirectorOct 31, 2016 Buy$13.00393,9235,120,9994,066,503Oct 31, 2016, 04:51 PM
Lettmann JasonDirectorOct 31, 2016 Sale$13.003404,42079,821Oct 31, 2016, 04:51 PM
Lettmann JasonDirectorOct 31, 2016 Option Exercise$0.0763,0194,41180,161Oct 31, 2016, 04:51 PM
MOTT DAVID M10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:51 PM
MOTT DAVID M10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:51 PM
MOTT DAVID M10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:51 PM
KOLLURI KRISHNA KITTU10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:50 PM
KOLLURI KRISHNA KITTU10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:50 PM
KOLLURI KRISHNA KITTU10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:50 PM
Novartis Bioventures Ltd10% OwnerOct 31, 2016 Buy$13.0084,6151,099,9952,545,652Oct 31, 2016, 04:50 PM
Novartis Bioventures Ltd10% OwnerOct 31, 2016 Sale$13.003394,40762,575Oct 31, 2016, 04:50 PM
Novartis Bioventures Ltd10% OwnerOct 31, 2016 Option Exercise$0.0762,9144,40462,914Oct 31, 2016, 04:50 PM
KERINS PATRICK J10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:50 PM
KERINS PATRICK J10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:50 PM
KERINS PATRICK J10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:50 PM
BASKETT FOREST10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:49 PM
BASKETT FOREST10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:49 PM
BASKETT FOREST10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:49 PM
BARRIS PETER J10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:49 PM
BARRIS PETER J10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:49 PM
BARRIS PETER J10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:49 PM
BARRETT M JAMES10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:48 PM
BARRETT M JAMES10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:48 PM
BARRETT M JAMES10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:48 PM
NEW ENTERPRISE ASSOCIATES 13 LP10% OwnerOct 31, 2016 Buy$13.00338,4624,400,0063,490,073Oct 31, 2016, 04:48 PM
NEW ENTERPRISE ASSOCIATES 13 LP10% OwnerOct 31, 2016 Sale$13.004355,65580,223Oct 31, 2016, 04:48 PM
NEW ENTERPRISE ASSOCIATES 13 LP10% OwnerOct 31, 2016 Option Exercise$0.0780,6585,64680,658Oct 31, 2016, 04:48 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Treco Douglas APresident and CEO04/02/202011,265,936
Lubner David CharlesExecutive VP and CFO04/02/2020749,856
Ricardo AlonsoSee Remarks04/02/2020142,704
Read SimonChief Scientific Officer04/02/2020604,560
Farzaneh-Far RaminChief Medical Officer04/02/2020695,616
King John CChief Commercial Officer04/02/2020519,504
Shah Rajeev M.Director04/02/2020233,196,480
RA CAPITAL MANAGEMENT, L.P.Director04/02/2020233,196,480
Ricardo AlonsoSee Remarks03/17/2020101,244
Farzaneh-Far RaminChief Medical Officer03/16/202059,332
Farzaneh-Far RaminChief Medical Officer03/16/2020478,521
Farzaneh-Far RaminChief Medical Officer02/18/202059,332
Farzaneh-Far RaminChief Medical Officer02/18/2020493,850
Ricardo AlonsoSee Remarks01/17/2020107,441
Farzaneh-Far RaminChief Medical Officer01/15/202059,332
Farzaneh-Far RaminChief Medical Officer01/15/2020497,441
Ricardo AlonsoSee Remarks12/17/2019107,568
Read SimonChief Scientific Officer12/17/201928,700
Read SimonChief Scientific Officer12/17/2019470,821
Farzaneh-Far RaminChief Medical Officer12/16/201959,332
Farzaneh-Far RaminChief Medical Officer12/16/2019500,351
Farzaneh-Far RaminChief Medical Officer11/15/201959,332
Farzaneh-Far RaminChief Medical Officer11/15/2019494,319
Read SimonChief Scientific Officer11/14/201928,700
Read SimonChief Scientific Officer11/14/2019466,808
Ricardo AlonsoSee Remarks10/17/2019106,710
Read SimonChief Scientific Officer10/16/201928,700
Read SimonChief Scientific Officer10/16/2019468,726
Farzaneh-Far RaminChief Medical Officer10/15/201959,332
Farzaneh-Far RaminChief Medical Officer10/15/2019496,769
Farzaneh-Far RaminChief Medical Officer09/16/201959,332
Farzaneh-Far RaminChief Medical Officer09/16/2019267,675
Read SimonChief Scientific Officer09/12/201928,700
Read SimonChief Scientific Officer09/12/2019254,050
Read SimonChief Scientific Officer08/23/201928,700
Read SimonChief Scientific Officer08/23/2019277,703
Farzaneh-Far RaminChief Medical Officer08/23/201959,332
Farzaneh-Far RaminChief Medical Officer08/23/2019294,226
Ricardo AlonsoSee Remarks08/23/201963,740
Read SimonChief Scientific Officer07/17/201928,700
Read SimonChief Scientific Officer07/17/2019329,479
Farzaneh-Far RaminChief Medical Officer07/15/201959,332
Farzaneh-Far RaminChief Medical Officer07/15/2019350,647
Ricardo AlonsoSee Remarks06/21/201967,782
Read SimonChief Scientific Officer06/18/201928,700
Read SimonChief Scientific Officer06/18/2019222,467
Farzaneh-Far RaminChief Medical Officer06/17/201959,332
Farzaneh-Far RaminChief Medical Officer06/17/2019231,384
King John CChief Commercial Officer04/16/201998,817
Lubner David CharlesExecutive V.P. & CFO02/01/201969,111
Read SimonChief Scientific Officer02/01/201961,593
Farzaneh-Far RaminChief Medical Officer02/01/201968,985
Treco Douglas APresident and CEO02/01/2019132,867
NEW ENTERPRISE ASSOCIATES 13 LP10% Owner12/14/20189,999,996
RA CAPITAL MANAGEMENT, LLCDirector12/12/201815,600,006
Shah Rajeev M.Director12/14/201815,600,006
NEW ENTERPRISE ASSOCIATES 13 LP10% Owner02/16/201812,000,000
Shah Rajeev M.Director02/14/201815,000,000
RA CAPITAL MANAGEMENT, LLCDirector02/14/201815,000,000
Novartis Bioventures Ltd10% Owner06/19/201770,899
Novartis Bioventures Ltd10% Owner06/16/20171,130,207
Novartis Bioventures Ltd10% Owner06/08/201715,400
Novartis Bioventures Ltd10% Owner06/07/2017106,999
Novartis Bioventures Ltd10% Owner06/06/2017167,161
Novartis Bioventures Ltd10% Owner06/02/2017348,949
Novartis Bioventures Ltd10% Owner06/05/2017110,488
Novartis Bioventures Ltd10% Owner06/01/2017256,176
Novartis Bioventures Ltd10% Owner05/31/2017850,896
Novartis Bioventures Ltd10% Owner05/26/2017133,267
Novartis Bioventures Ltd10% Owner05/25/20171,325
Novartis Bioventures Ltd10% Owner05/24/2017436,364
Novartis Bioventures Ltd10% Owner05/18/2017229,964
Novartis Bioventures Ltd10% Owner05/17/2017574,901
Novartis Bioventures Ltd10% Owner05/16/2017528,725
Novartis Bioventures Ltd10% Owner02/23/2017105,160
Novartis Bioventures Ltd10% Owner02/22/201716,370
Novartis Bioventures Ltd10% Owner03/01/2017162,658
Novartis Bioventures Ltd10% Owner02/28/2017163,670
Novartis Bioventures Ltd10% Owner02/27/20171,212,306
Novartis Bioventures Ltd10% Owner02/24/2017113,000
Novo A/S10% Owner10/31/20163,200,002
Shah Rajeev M.Director10/31/20162,099,994
RA CAPITAL MANAGEMENT, LLCDirector10/31/20162,099,994
Weller Harry R10% Owner10/31/20164,400,006
Weller Harry R10% Owner10/31/20165,655
Weller Harry R10% Owner10/31/20165,646
MORGENTHALER VENTURE PARTNERS IX LP10% Owner10/31/20163,425,994
MORGENTHALER VENTURE PARTNERS IX LP10% Owner10/31/20164,420
MORGENTHALER VENTURE PARTNERS IX LP10% Owner10/31/20164,411
Viswanathan Ravi10% Owner10/31/20164,400,006
Viswanathan Ravi10% Owner10/31/20165,655
Viswanathan Ravi10% Owner10/31/20165,646
SANDELL SCOTT D10% Owner10/31/20164,400,006
SANDELL SCOTT D10% Owner10/31/20165,655
SANDELL SCOTT D10% Owner10/31/20165,646
Lettmann JasonDirector10/31/20165,120,999
Lettmann JasonDirector10/31/20164,420
Lettmann JasonDirector10/31/20164,411
MOTT DAVID M10% Owner10/31/20164,400,006
MOTT DAVID M10% Owner10/31/20165,655
MOTT DAVID M10% Owner10/31/20165,646
KOLLURI KRISHNA KITTU10% Owner10/31/20164,400,006
KOLLURI KRISHNA KITTU10% Owner10/31/20165,655
KOLLURI KRISHNA KITTU10% Owner10/31/20165,646
Novartis Bioventures Ltd10% Owner10/31/20161,099,995
Novartis Bioventures Ltd10% Owner10/31/20164,407
Novartis Bioventures Ltd10% Owner10/31/20164,404
KERINS PATRICK J10% Owner10/31/20164,400,006
KERINS PATRICK J10% Owner10/31/20165,655
KERINS PATRICK J10% Owner10/31/20165,646
BASKETT FOREST10% Owner10/31/20164,400,006
BASKETT FOREST10% Owner10/31/20165,655
BASKETT FOREST10% Owner10/31/20165,646
BARRIS PETER J10% Owner10/31/20164,400,006
BARRIS PETER J10% Owner10/31/20165,655
BARRIS PETER J10% Owner10/31/20165,646
BARRETT M JAMES10% Owner10/31/20164,400,006
BARRETT M JAMES10% Owner10/31/20165,655
BARRETT M JAMES10% Owner10/31/20165,646
NEW ENTERPRISE ASSOCIATES 13 LP10% Owner10/31/20164,400,006
NEW ENTERPRISE ASSOCIATES 13 LP10% Owner10/31/20165,655
NEW ENTERPRISE ASSOCIATES 13 LP10% Owner10/31/20165,646
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR RA PHARMACEUTICALS, INC.
LOADING...